Search Results - "Gozalov, Ogtay"

Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018 by Buziashvili, Mariana, Davtyan, Hayk, Sereda, Yuliia, Denisiuk, Olga, Gozalov, Ogtay, Lomtadze, Nino, Hovhannesyan, Arax

“…Considering the complexity of second-line anti-tuberculosis (TB) treatment regimens, the management of drug-resistant TB (DR-TB) in Georgia remains a major…”
Get full text

Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan by Gadoev, Jamshid, Asadov, Damin, Harries, Anthony D, Parpieva, Nargiza, Tayler-Smith, Katie, Isaakidis, Petros, Ali, Engy, Hinderaker, Sven Gudmund, Ogtay, Gozalov, Ramsay, Andrew, Jalolov, Avazbek, Dara, Masoud

“…In Uzbekistan, despite stable and relatively high tuberculosis treatment success rates, relatively high rates of recurrent tuberculosis have recently been…”
Get full text

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020 by Avaliani, Teona, Sereda, Yuliia, Davtyan, Hayk, Tukvadze, Nestani, Togonidze, Tamar, Kiria, Nana, Denisiuk, Olga, Gozalov, Ogtay, Ahmedov, Sevim, Hovhannesyan, Arax

“…Tuberculosis treatment is challenging, especially among people with drug-resistant forms of tuberculosis. The introduction of fully oral modified short…”
Get full text

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study by Gadoev, Jamshid, Asadov, Damin, Tillashaykhov, Mirzagolib, Tayler-Smith, Katie, Isaakidis, Petros, Dadu, Andrei, de Colombani, Pierpaolo, Gudmund Hinderaker, Sven, Parpieva, Nargiza, Ulmasova, Dilrabo, Jalolov, Avazbek, Hamraev, Atadjan, Ali, Engy, Boom, Martin van den, Hammerich, Asmus, Gozalov, Ogtay, Dara, Masoud

“…TB is one of the main health priorities in Uzbekistan and relatively high rates of unfavorable treatment outcomes have recently been reported. This requires…”
Get full text

Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study by Diktanas, Saulius, Korotych, Oleksandr, Sereda, Yuliia, Gozalov, Ogtay, Rubcova, Olga, Achar, Jay

“…The global proportion of successful treatment outcomes of Multidrug-Resistant/Rifampicin-Resistant Tuberculosis (MDR/RR-TB) remains unacceptably low. Time to…”
Get full text

What is behind programmatic treatment outcome definitions for tuberculosis? by Avaliani, Zaza, Gozalov, Ogtay, Kuchukhidze, Giorgi, Skrahina, Alena, Soltan, Viorel, van den Boom, Martin, Vasilyeva, Irina, Vilc, Valentina, Yedilbayev, Askar

Get full text

Tuberculosis Notification Trends and Treatment Outcomes in Penitentiary and Civilian Health Care Sectors in the WHO European Region by Dadu, Andrei, Ciobanu, Ana, Hovhannesyan, Araksya, Alikhanova, Natavan, Korotych, Oleksandr, Gurbanova, Elmira, Mehdiyev, Rafael, Doltu, Svetlana, Gozalov, Ogtay, Ahmedov, Sevim, Dara, Masoud

“…Setting: Tuberculosis (TB) morbidity in penitentiary sectors is one of the major barriers to ending TB in the World Health Organization (WHO) European Region…”
Get full text